MARIANNE YOUNGBLOOD: Open Payments
NPI 1033502745 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 62 payments from 17 companies in 2025. Trend: 2023 $324 · 2024 $359 · 2025 $1,065
Food & beverage: $1,065
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 20 | $231 |
| Novo Nordisk Inc | 11 | $170 |
| Axsome Therapeutics, Inc. | 5 | $106 |
| Antares Pharma, Inc. | 2 | $85 |
| Lilly USA, LLC | 5 | $76 |
| ABBVIE INC. | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Verity Pharmaceuticals Inc. | 2 | $32 |
Products named: REPATHA, Auvelity, Rybelsus, XYOSTED, OTEZLA, MOUNJARO, VOQUEZNA, LEQVIO.
Industry payments across TX — which companies pay providers there.
